Articles

Editorial

10.4244/EIJ-E-25-00051 Jan 5, 2026
QFR in clinical practice: raising the bar for quality and reproducibility
Lansky A
free

Viewpoint

10.4244/EIJ-D-25-01167 Jan 5, 2026
High-risk plaques: intervene early or hold the line?
Mintz G, Collet C
free

Expert Review

10.4244/EIJ-D-25-00263 Jan 5, 2026
Endomyocardial biopsy
Fabris E, Porcari A, Bussani R, Pinamonti M, Merlo M, Rakar S, Perkan A, Bartunek J, Sinagra G
free

Original Research

10.4244/EIJ-D-25-00648 Jan 5, 2026
Long-term clinical outcomes of non-culprit plaque rupture in STEMI
Zhao J, Zhao R, Chen Y, Cui L, Ma X, Chen J, Dong F, Lin T, Tan J, Wu T, Jin C, Xiu L, Wang W, Li L, Wang Y, Jiang S, Yu H, Hou J, Fang C, Dai J, Yu B

Original Research

10.4244/EIJ-D-25-00671 Jan 5, 2026
Non-invasive assessment of microcirculatory resistance by coronary computed tomography angiography
Deng D, Zhu P, Qu X, Li H, Xue X, Liu X, Gao Z, Zhang H, Qin H, Lu Y, Feng Y, Zeng M, Chen S, Li X, Zhou Y, Liu F, Gao H, Zheng W, Zhang C, Xu X, Chen W, Yi D, Papanastasiou G, Hau W, Yang G, Zhang Z
open access

Original Research

10.4244/EIJ-D-25-00668 Jan 5, 2026
Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study
Kristensen S, Holm M, Maillard L, Råmunddal T, Guiducci V, Stähli B, Žiubrytė G, Westra J, Van Belle E, Erriquez A, Kołtowski Ł, Mogensen LJH, Escaned J, Christiansen E, Holm N, Andersen B, the FAVOR III Europe study team o

Research Correspondence

10.4244/EIJ-D-25-00574 Jan 5, 2026
Management and outcomes of patients with ST-segment elevation myocardial infarction and large infarct-related arteries
Bonnet M, Belle L, Pilichowski H, Cassar E, Rias S, Morelle J, Gibault Genty G, Roule V, Verheyde H, Pouillot C, Chanseaume S, Hess S, Jeanneteau J, Durel N, Riccini P, Tixier V, Lazizi T, Gommeaux A, Tarragano F, Cuisset T, Barone Rochette G, Chassaing S, Cayla G, Commeau P, Benamer H, Koning R, Van Belle E, Zeitouni M, Puymirat E, Mangin L, Motreff P, Rangé G

Trial Design

10.4244/EIJ-D-25-01090 Dec 22, 2025
Transcatheter Valve-in-Valve versus redo-Surgical Valve Replacement for Mitral Bioprosthetic Valve Dysfunction: Rationale and Design of the SURVIV randomised trial
Siqueira D, Abizaid A, Ramos A, Issa M, Cervone A, Bezerra C, de Araripe Falcão B, Cortes L, de Freitas C. Guimarães L, K. São Thiago L, Rezende M, Rolemberg Delamain T, Della Togna D, Assef J, Vilela A, Paladino A, Pinto I, Franchini K, Bhatt D, Feres F
free

State-of-the-Art

10.4244/EIJ-D-25-00116 Dec 15, 2025
Transcatheter edge-to-edge repair in secondary mitral regurgitation
Rodés-Cabau J, Mengi S, Salaun E, Paradis J, Abraham W
free

Original Research

10.4244/EIJ-D-25-00757 Dec 15, 2025
Watchman FLX versus Watchman 2.5 for left atrial appendage closure: a propensity score-matched analysis
Galea R, La Fazia V, Della Rocca D, Gasys A, Bini T, Siontis G, Gianni C, Roten L, Mohanty S, Brugger N, Torlapati P, Horton R, Al-Ahmad A, Biase L, Natale A, Räber L

Original Research

10.4244/EIJ-D-25-00489 Dec 15, 2025
Predictors of underexpansion after transcatheter aortic valve implantation with the ACURATE neo valve
Alvarez-Covarrubias H, Taniguchi Y, Jurisic M, Altaner N, Syryca F, Blum E, Pellegrini C, Duesmann C, Mayr N, Rheude T, Schunkert H, Kastrati A, Cassese S, Xhepa E, Joner M

Original Research

10.4244/EIJ-D-24-01168 Dec 15, 2025
Feasibility of valve-in-root transcatheter aortic valve implantation in patients with prior aortic root replacement and repair
Zientara A, Brizzi F, von zur Mühlen C, Bruijnen H, Kreibich M, Berger T, Kondov S, Siepe M, Rylski B, Benk J, Beyersdorf F, Rilinger J, Maier A, Oettinger V, Westermann D, Czerny M, Gottardi R

Research Correspondence

10.4244/EIJ-D-25-00319 Dec 15, 2025
Phenotyping coronary microvascular dysfunction endotypes using invasive exercise stress testing
Rahoual G, Procopi N, Beaupré F, Michon M, Martinez C, Guedeney P, Hammoudi N, Hatem S, Vicaut E, Kerneis M, Silvain J, Montalescot G, Zeitouni M, of the ACTION Study Group o

Research Correspondence

10.4244/EIJ-D-25-00667 Dec 15, 2025
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in percutaneous coronary intervention: five-year outcomes of the SORT OUT X randomised clinical trial
Jakobsen L, Christiansen E, Frøslev T, Raungaard B, Lassen J, Eftekhari A, Jensen L
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved